GlassScriptPhysician profile
Apeksha Patel
NPI 1235587007
$1,329.15
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $813 · 2020: $480 · 2021: $20.19 · 2022: $15.86.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $132.57 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $126.56 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $124.50 | 2019 | |
| Novo Nordisk INC | $122.67 | 2019-2020 | |
| Abbvie INC. | $109.34 | 2019-2022 | |
| Glaxosmithkline, LLC. | $102.60 | 2019-2020 | |
| Lilly USA, LLC | $96.62 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $81.76 | 2019 | |
| Janssen Pharmaceuticals, INC | $72.69 | 2019-2021 | |
| Pfizer INC. | $56.37 | 2019-2020 | |
| Amarin Pharma, INC. | $52.86 | 2019-2020 | |
| Amgen INC. | $45.90 | 2020 | |
| Merck Sharp & Dohme LLC | $39.58 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $27.84 | 2019-2020 | |
| Astellas Pharma US INC | $23.84 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $21.87 | 2020 | |
| Bausch Health US, LLC | $18.93 | 2020 | |
| Ironshore Pharmaceuticals INC. | $18.10 | 2019 | |
| Ironwood Pharmaceuticals, INC | $15.26 | 2020 | |
| Arbor Pharmaceuticals, INC. | $14.85 | 2019 | |
| Shire North American Group INC | $13.12 | 2019 | |
| Hikma Pharmaceuticals USA | $11.32 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Apeksha Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.